Top Chinese Dividend Stocks To Watch In August 2024

Amid mixed performance in Chinese equities, with the Shanghai Composite Index gaining 0.5% and the blue-chip CSI 300 losing 0.73%, investors are closely monitoring economic indicators such as manufacturing data and industrial profits. In this context, dividend stocks can offer a measure of stability and income, making them an attractive option for those looking to navigate current market uncertainties while benefiting from potential long-term growth.

Top 10 Dividend Stocks In China

Name	Dividend Yield	Dividend Rating
Midea Group (SZSE:000333)	4.76%	★★★★★★
Changhong Meiling (SZSE:000521)	3.67%	★★★★★★
Wuliangye YibinLtd (SZSE:000858)	3.78%	★★★★★★
Ping An Bank (SZSE:000001)	7.09%	★★★★★★
Inner Mongolia Yili Industrial Group (SHSE:600887)	4.91%	★★★★★★
China South Publishing & Media Group (SHSE:601098)	4.70%	★★★★★★
Huangshan NovelLtd (SZSE:002014)	5.97%	★★★★★★
HUAYU Automotive Systems (SHSE:600741)	4.90%	★★★★★★
Chacha Food Company (SZSE:002557)	3.84%	★★★★★★
Zhejiang Jiaxin SilkLtd (SZSE:002404)	5.55%	★★★★★★

Click here to see the full list of 256 stocks from our Top Chinese Dividend Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Time Publishing and Media (SHSE:600551)

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Time Publishing and Media Co., Ltd. publishes various books and periodicals in China, with a market cap of CN¥5.09 billion.

Operations: Time Publishing and Media Co., Ltd. generates revenue through the publication of various books and periodicals in China.

Dividend Yield: 4.8%

Time Publishing and Media offers a compelling dividend yield of 4.76%, placing it in the top 25% of dividend payers in China. The company's dividends are well-covered by earnings (Payout Ratio: 45.7%) and cash flows (Cash Payout Ratio: 32.8%). Despite this, its dividend track record has been unstable over the past decade, with notable volatility. Additionally, while recent earnings grew by 51.4%, future earnings are forecast to decline by an average of 6.4% annually over the next three years.

• Click here and access our complete dividend analysis report to understand the dynamics of Time Publishing and Media.
• In light of our recent valuation report, it seems possible that Time Publishing and Media is trading behind its estimated value.

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Star Lake Bioscience Co., Inc.Zhaoqing Guangdong manufactures and sells pharmaceutical raw materials, food, and feed additives under the Star Lake and Yue Bao brands both in China and internationally, with a market cap of CN¥9.35 billion.

Operations: Star Lake Bioscience Co., Inc.Zhaoqing Guangdong generates revenue primarily from the manufacture and sale of pharmaceutical raw materials, as well as food and feed additives.

Dividend Yield: 6.7%

Star Lake BioscienceZhaoqing Guangdong's dividends are covered by earnings (Payout Ratio: 78%) and cash flows (Cash Payout Ratio: 29.4%). Although the dividend yield is in the top 25% of dividend payers in China, it's too early to determine if the payments will be stable or reliable due to their recent initiation. The stock trades at a good value, but it has a high level of debt and has experienced significant share price volatility recently.

• Dive into the specifics of Star Lake BioscienceZhaoqing Guangdong here with our thorough dividend report.
• Upon reviewing our latest valuation report, Star Lake BioscienceZhaoqing Guangdong's share price might be too pessimistic.

Zhejiang Jolly PharmaceuticalLTD (SZSE:300181)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Zhejiang Jolly Pharmaceutical Co., LTD is involved in the research, production, and marketing of Chinese medicinal products both domestically and internationally, with a market cap of CN¥10.25 billion.

Operations: Zhejiang Jolly Pharmaceutical Co., LTD generates revenue through its research, production, and marketing of Chinese medicinal products in the People’s Republic of China and abroad.

Dividend Yield: 3.1%

Zhejiang Jolly Pharmaceutical's dividend yield is in the top 25% of payers in China at 3.08%, but its dividends are not well covered by free cash flows (128.8% payout ratio) and have been volatile over the past decade. Despite a reasonable earnings payout ratio of 65.1%, recent earnings growth and a CNY 300 million share buyback program highlight efforts to stabilize and promote sustained development, though dividend reliability remains a concern.

• Click to explore a detailed breakdown of our findings in Zhejiang Jolly PharmaceuticalLTD's dividend report.
• The analysis detailed in our Zhejiang Jolly PharmaceuticalLTD valuation report hints at an deflated share price compared to its estimated value.

Seize The Opportunity

• Click this link to deep-dive into the 256 companies within our Top Chinese Dividend Stocks screener.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com